“…Pregabalin, an anticonvulsant and anxiolytic drug (Figure 1), is widely used to treat epilepsy, generalized anxiety disorder (Pregabalin, 2019), neuropathic pain (Frampton, 2014), restless leg syndrome and fibromyalgia (Iftikhar et al, 2017). Naringin, a flavonoid (Figure 1b), has been extensively explored both in vivo and in vitro and found to exhibit multifaceted pharmacological activities which include antiasthmatic (Gupta, Adin, Aqil, & Mujeeb, 2022), antiosteoporotic (Gupta, Adin, Aqil, Mujeeb, & Ahad, 2022), antiapoptotic (Adin, Gupta, Ahad, et al, 2022; Gupta, Adin, Aqil, & Mujeeb, 2022), antitumor (Adin, Gupta, Ali, et al, 2022; Gupta, Adin, Aqil, & Mujeeb, 2022), antioxidant (Adin, Gupta, Ali, et al, 2022; Gupta, Adin, Aqil, & Mujeeb, 2022), anti‐infammatory (Adin, Gupta, Aqil, & Mujeeb, 2022; Gupta, Adin, Aqil, & Mujeeb, 2022), anti‐ulcer (Adinet al, 2023a; Gupta, Adin, Aqil, & Mujeeb, 2022), neuroprotective (Adin, Gupta, Aqil, Mujeeb, & Ahad, 2023; Gupta, Adin, Aqil, & Mujeeb, 2022), anxiolytic (Adinet al, 2023b; Gupta, Adin, Aqil, & Mujeeb, 2022) and anticarcinogenic activities (Adin, Gupta, Aqil, et al, 2023; Gupta, Adin, Aqil, & Mujeeb, 2023). A combination of PRG and NRN is expected to be effective against neuropathic pain, anxiety and epilepsy owing to their therapeutic potential.…”